Depletion of cytosolic phospholipase A 2 in bone marrow-derived macrophages protects against lung cancer progression and metastasis

Mary C M Weiser-Evans, Xue Qing Wang, Jay Amin, Vicki Van Putten, Rashmi Choudhary, Robert A. Winn, Robert Scheinman, Peter Simpson, Mark W. Geraci, Raphael A. Nemenoff

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Cancer progression and metastasis involves interactions between tumor cells and the tumor microenvironment (TME). We reported that mice deficient for cytosolic phospholipase A2 (cPLA2-KO) are protected against the development of lung tumors. The goal of this study was to examine the role of CPLA2 in the TME. Mouse lung cancer cells (CMT167 and Lewis lung carcinoma cells) injected directly into lungs of syngeneic mice formed a primary tumor, and then metastasized to other lobes of the lung and to the mediastinal lymph nodes. Identical cells injected into CPLA2-KO mice showed a dramatic decrease in the numbers of secondary metastatic tumors. This was associated with decreased macrophage staining surrounding the tumor. Wild-type mice transplanted with CPLA2-KO bone marrow had a marked survival advantage after inoculation with tumor cells compared with mice receiving wild-type (WT) bone marrow. In vitro, coculturing CMT167 cells with bone marrow-derived macrophages from WT mice increased production of interleukin 6 (IL-6) by cancer cells. This increase was blocked in cocultures using CPLA2-KO macrophages. Correspondingly, IL-6 staining was decreased in tumors grown in CPLA2-KO mice. These data suggest that stromal CPLA2 plays a critical role in tumor progression by altering tumor-macrophage interactions and cytokine production,

Original languageEnglish (US)
Pages (from-to)1733-1738
Number of pages6
JournalCancer Research
Volume69
Issue number5
DOIs
StatePublished - Mar 1 2009
Externally publishedYes

Fingerprint

Phospholipases A
Lung Neoplasms
Macrophages
Neoplasm Metastasis
Neoplasms
Tumor Microenvironment
Lung
Interleukin-6
Bone Marrow
Cytosolic Phospholipases A2
Staining and Labeling
Lewis Lung Carcinoma
Cellular Microenvironment
Coculture Techniques
Lymph Nodes
Cytokines

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Weiser-Evans, M. C. M., Wang, X. Q., Amin, J., Van Putten, V., Choudhary, R., Winn, R. A., ... Nemenoff, R. A. (2009). Depletion of cytosolic phospholipase A 2 in bone marrow-derived macrophages protects against lung cancer progression and metastasis. Cancer Research, 69(5), 1733-1738. https://doi.org/10.1158/0008-5472.CAN-08-3766

Depletion of cytosolic phospholipase A 2 in bone marrow-derived macrophages protects against lung cancer progression and metastasis. / Weiser-Evans, Mary C M; Wang, Xue Qing; Amin, Jay; Van Putten, Vicki; Choudhary, Rashmi; Winn, Robert A.; Scheinman, Robert; Simpson, Peter; Geraci, Mark W.; Nemenoff, Raphael A.

In: Cancer Research, Vol. 69, No. 5, 01.03.2009, p. 1733-1738.

Research output: Contribution to journalArticle

Weiser-Evans, MCM, Wang, XQ, Amin, J, Van Putten, V, Choudhary, R, Winn, RA, Scheinman, R, Simpson, P, Geraci, MW & Nemenoff, RA 2009, 'Depletion of cytosolic phospholipase A 2 in bone marrow-derived macrophages protects against lung cancer progression and metastasis', Cancer Research, vol. 69, no. 5, pp. 1733-1738. https://doi.org/10.1158/0008-5472.CAN-08-3766
Weiser-Evans, Mary C M ; Wang, Xue Qing ; Amin, Jay ; Van Putten, Vicki ; Choudhary, Rashmi ; Winn, Robert A. ; Scheinman, Robert ; Simpson, Peter ; Geraci, Mark W. ; Nemenoff, Raphael A. / Depletion of cytosolic phospholipase A 2 in bone marrow-derived macrophages protects against lung cancer progression and metastasis. In: Cancer Research. 2009 ; Vol. 69, No. 5. pp. 1733-1738.
@article{3e444fa69b54437bacb7693c762fcdfe,
title = "Depletion of cytosolic phospholipase A 2 in bone marrow-derived macrophages protects against lung cancer progression and metastasis",
abstract = "Cancer progression and metastasis involves interactions between tumor cells and the tumor microenvironment (TME). We reported that mice deficient for cytosolic phospholipase A2 (cPLA2-KO) are protected against the development of lung tumors. The goal of this study was to examine the role of CPLA2 in the TME. Mouse lung cancer cells (CMT167 and Lewis lung carcinoma cells) injected directly into lungs of syngeneic mice formed a primary tumor, and then metastasized to other lobes of the lung and to the mediastinal lymph nodes. Identical cells injected into CPLA2-KO mice showed a dramatic decrease in the numbers of secondary metastatic tumors. This was associated with decreased macrophage staining surrounding the tumor. Wild-type mice transplanted with CPLA2-KO bone marrow had a marked survival advantage after inoculation with tumor cells compared with mice receiving wild-type (WT) bone marrow. In vitro, coculturing CMT167 cells with bone marrow-derived macrophages from WT mice increased production of interleukin 6 (IL-6) by cancer cells. This increase was blocked in cocultures using CPLA2-KO macrophages. Correspondingly, IL-6 staining was decreased in tumors grown in CPLA2-KO mice. These data suggest that stromal CPLA2 plays a critical role in tumor progression by altering tumor-macrophage interactions and cytokine production,",
author = "Weiser-Evans, {Mary C M} and Wang, {Xue Qing} and Jay Amin and {Van Putten}, Vicki and Rashmi Choudhary and Winn, {Robert A.} and Robert Scheinman and Peter Simpson and Geraci, {Mark W.} and Nemenoff, {Raphael A.}",
year = "2009",
month = "3",
day = "1",
doi = "10.1158/0008-5472.CAN-08-3766",
language = "English (US)",
volume = "69",
pages = "1733--1738",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Depletion of cytosolic phospholipase A 2 in bone marrow-derived macrophages protects against lung cancer progression and metastasis

AU - Weiser-Evans, Mary C M

AU - Wang, Xue Qing

AU - Amin, Jay

AU - Van Putten, Vicki

AU - Choudhary, Rashmi

AU - Winn, Robert A.

AU - Scheinman, Robert

AU - Simpson, Peter

AU - Geraci, Mark W.

AU - Nemenoff, Raphael A.

PY - 2009/3/1

Y1 - 2009/3/1

N2 - Cancer progression and metastasis involves interactions between tumor cells and the tumor microenvironment (TME). We reported that mice deficient for cytosolic phospholipase A2 (cPLA2-KO) are protected against the development of lung tumors. The goal of this study was to examine the role of CPLA2 in the TME. Mouse lung cancer cells (CMT167 and Lewis lung carcinoma cells) injected directly into lungs of syngeneic mice formed a primary tumor, and then metastasized to other lobes of the lung and to the mediastinal lymph nodes. Identical cells injected into CPLA2-KO mice showed a dramatic decrease in the numbers of secondary metastatic tumors. This was associated with decreased macrophage staining surrounding the tumor. Wild-type mice transplanted with CPLA2-KO bone marrow had a marked survival advantage after inoculation with tumor cells compared with mice receiving wild-type (WT) bone marrow. In vitro, coculturing CMT167 cells with bone marrow-derived macrophages from WT mice increased production of interleukin 6 (IL-6) by cancer cells. This increase was blocked in cocultures using CPLA2-KO macrophages. Correspondingly, IL-6 staining was decreased in tumors grown in CPLA2-KO mice. These data suggest that stromal CPLA2 plays a critical role in tumor progression by altering tumor-macrophage interactions and cytokine production,

AB - Cancer progression and metastasis involves interactions between tumor cells and the tumor microenvironment (TME). We reported that mice deficient for cytosolic phospholipase A2 (cPLA2-KO) are protected against the development of lung tumors. The goal of this study was to examine the role of CPLA2 in the TME. Mouse lung cancer cells (CMT167 and Lewis lung carcinoma cells) injected directly into lungs of syngeneic mice formed a primary tumor, and then metastasized to other lobes of the lung and to the mediastinal lymph nodes. Identical cells injected into CPLA2-KO mice showed a dramatic decrease in the numbers of secondary metastatic tumors. This was associated with decreased macrophage staining surrounding the tumor. Wild-type mice transplanted with CPLA2-KO bone marrow had a marked survival advantage after inoculation with tumor cells compared with mice receiving wild-type (WT) bone marrow. In vitro, coculturing CMT167 cells with bone marrow-derived macrophages from WT mice increased production of interleukin 6 (IL-6) by cancer cells. This increase was blocked in cocultures using CPLA2-KO macrophages. Correspondingly, IL-6 staining was decreased in tumors grown in CPLA2-KO mice. These data suggest that stromal CPLA2 plays a critical role in tumor progression by altering tumor-macrophage interactions and cytokine production,

UR - http://www.scopus.com/inward/record.url?scp=62449343121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62449343121&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-08-3766

DO - 10.1158/0008-5472.CAN-08-3766

M3 - Article

C2 - 19208832

AN - SCOPUS:62449343121

VL - 69

SP - 1733

EP - 1738

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 5

ER -